ºÝºÝߣshows by User: WessexAHSN / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: WessexAHSN / Wed, 04 Dec 2024 17:36:19 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: WessexAHSN Innovation Ecosystem Programme rapid insight recommendations November 2024.pdf /slideshow/innovation-ecosystem-programme-rapid-insight-recommendations-november-2024-pdf/273838536 iepfinalreporthealthinnovationnetworknovember2024-241204173619-0224cd7b
During December 2023 – February 2024 the NHS England Innovation, Research, Life Sciences and Strategy (IRLSS) team, along with Health Innovation Wessex, Health Innovation West of England and Health Innovation South West, delivered a series of learning collaboratives to support Workstream 1: Learning by Doing as part of the Innovation Ecosystem Programme (IEP). On 16 October 2024, the IRLSS team, along with Health Innovation Wessex and Health Innovation West of England, provided colleagues from health innovation networks, integrated care boards, providers and academic institutions with a unique opportunity to hear more about the progression of the Innovation Ecosystem Programme (IEP) and to learn more about the launch of the locality partnership. The rapid insight event explored four key questions and offered a wealth of insights into the challenges and opportunities of implementing and embedding the emergent Innovation Ecosystem recommendations. This report and its findings were incorporated into NHS England's final Innovation Ecosystem Programme report in November 2024.]]>
During December 2023 – February 2024 the NHS England Innovation, Research, Life Sciences and Strategy (IRLSS) team, along with Health Innovation Wessex, Health Innovation West of England and Health Innovation South West, delivered a series of learning collaboratives to support Workstream 1: Learning by Doing as part of the Innovation Ecosystem Programme (IEP). On 16 October 2024, the IRLSS team, along with Health Innovation Wessex and Health Innovation West of England, provided colleagues from health innovation networks, integrated care boards, providers and academic institutions with a unique opportunity to hear more about the progression of the Innovation Ecosystem Programme (IEP) and to learn more about the launch of the locality partnership. The rapid insight event explored four key questions and offered a wealth of insights into the challenges and opportunities of implementing and embedding the emergent Innovation Ecosystem recommendations. This report and its findings were incorporated into NHS England's final Innovation Ecosystem Programme report in November 2024.]]> Wed, 04 Dec 2024 17:36:19 GMT /slideshow/innovation-ecosystem-programme-rapid-insight-recommendations-november-2024-pdf/273838536 WessexAHSN@slideshare.net(WessexAHSN) Innovation Ecosystem Programme rapid insight recommendations November 2024.pdf WessexAHSN During December 2023 – February 2024 the NHS England Innovation, Research, Life Sciences and Strategy (IRLSS) team, along with Health Innovation Wessex, Health Innovation West of England and Health Innovation South West, delivered a series of learning collaboratives to support Workstream 1: Learning by Doing as part of the Innovation Ecosystem Programme (IEP). On 16 October 2024, the IRLSS team, along with Health Innovation Wessex and Health Innovation West of England, provided colleagues from health innovation networks, integrated care boards, providers and academic institutions with a unique opportunity to hear more about the progression of the Innovation Ecosystem Programme (IEP) and to learn more about the launch of the locality partnership. The rapid insight event explored four key questions and offered a wealth of insights into the challenges and opportunities of implementing and embedding the emergent Innovation Ecosystem recommendations. This report and its findings were incorporated into NHS England's final Innovation Ecosystem Programme report in November 2024. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iepfinalreporthealthinnovationnetworknovember2024-241204173619-0224cd7b-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> During December 2023 – February 2024 the NHS England Innovation, Research, Life Sciences and Strategy (IRLSS) team, along with Health Innovation Wessex, Health Innovation West of England and Health Innovation South West, delivered a series of learning collaboratives to support Workstream 1: Learning by Doing as part of the Innovation Ecosystem Programme (IEP). On 16 October 2024, the IRLSS team, along with Health Innovation Wessex and Health Innovation West of England, provided colleagues from health innovation networks, integrated care boards, providers and academic institutions with a unique opportunity to hear more about the progression of the Innovation Ecosystem Programme (IEP) and to learn more about the launch of the locality partnership. The rapid insight event explored four key questions and offered a wealth of insights into the challenges and opportunities of implementing and embedding the emergent Innovation Ecosystem recommendations. This report and its findings were incorporated into NHS England&#39;s final Innovation Ecosystem Programme report in November 2024.
Innovation Ecosystem Programme rapid insight recommendations November 2024.pdf from Health Innovation Wessex
]]> 216 0 https://cdn.slidesharecdn.com/ss_thumbnails/iepfinalreporthealthinnovationnetworknovember2024-241204173619-0224cd7b-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Data, Digital and AI strategic event slides /slideshow/data-digital-and-ai-strategic-event-slides/273781325 slidesforsharing2-241202155010-1c5563ed
Health Innovation Wessex Data, Digital and AI strategic event slides from November 19, 2024]]>
Health Innovation Wessex Data, Digital and AI strategic event slides from November 19, 2024]]> Mon, 02 Dec 2024 15:50:10 GMT /slideshow/data-digital-and-ai-strategic-event-slides/273781325 WessexAHSN@slideshare.net(WessexAHSN) Data, Digital and AI strategic event slides WessexAHSN Health Innovation Wessex Data, Digital and AI strategic event slides from November 19, 2024 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/slidesforsharing2-241202155010-1c5563ed-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Health Innovation Wessex Data, Digital and AI strategic event slides from November 19, 2024
Data, Digital and AI strategic event slides from Health Innovation Wessex
]]> 569 0 https://cdn.slidesharecdn.com/ss_thumbnails/slidesforsharing2-241202155010-1c5563ed-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Strategic Event slides - Data, Digital and AI /slideshow/strategic-event-slides-data-digital-and-ai/273774963 slidesforsharing-241202105916-8cdb3d62
A set of the slides from presenters sharing their innovations at our strategic event held on 18 November 2024.]]>
A set of the slides from presenters sharing their innovations at our strategic event held on 18 November 2024.]]> Mon, 02 Dec 2024 10:59:16 GMT /slideshow/strategic-event-slides-data-digital-and-ai/273774963 WessexAHSN@slideshare.net(WessexAHSN) Strategic Event slides - Data, Digital and AI WessexAHSN A set of the slides from presenters sharing their innovations at our strategic event held on 18 November 2024. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/slidesforsharing-241202105916-8cdb3d62-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> A set of the slides from presenters sharing their innovations at our strategic event held on 18 November 2024.
Strategic Event slides - Data, Digital and AI from Health Innovation Wessex
]]> 371 0 https://cdn.slidesharecdn.com/ss_thumbnails/slidesforsharing-241202105916-8cdb3d62-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Reducing opioid prescribing (in general practice) /slideshow/reducing-opioid-prescribing-in-general-practice/266273916 reducingopioidprescribingsreeseelamqipster-240212105329-4138ab6d
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Mon, 12 Feb 2024 10:53:29 GMT /slideshow/reducing-opioid-prescribing-in-general-practice/266273916 WessexAHSN@slideshare.net(WessexAHSN) Reducing opioid prescribing (in general practice) WessexAHSN The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/reducingopioidprescribingsreeseelamqipster-240212105329-4138ab6d-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Reducing opioid prescribing (in general practice) from Health Innovation Wessex
]]> 57 0 https://cdn.slidesharecdn.com/ss_thumbnails/reducingopioidprescribingsreeseelamqipster-240212105329-4138ab6d-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes /slideshow/pharmacist-interventions-and-medication-reviews-at-care-homes-improving-medication-safety-and-patient-outcomes/266273574 vaneetaanandpharmacistinterventionsandmedicationreviewsatcarehomesarcprimarycarenetworkimprovingmedi-240212102634-a94b5ceb
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Mon, 12 Feb 2024 10:26:34 GMT /slideshow/pharmacist-interventions-and-medication-reviews-at-care-homes-improving-medication-safety-and-patient-outcomes/266273574 WessexAHSN@slideshare.net(WessexAHSN) Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes WessexAHSN The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/vaneetaanandpharmacistinterventionsandmedicationreviewsatcarehomesarcprimarycarenetworkimprovingmedi-240212102634-a94b5ceb-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes from Health Innovation Wessex
]]> 190 0 https://cdn.slidesharecdn.com/ss_thumbnails/vaneetaanandpharmacistinterventionsandmedicationreviewsatcarehomesarcprimarycarenetworkimprovingmedi-240212102634-a94b5ceb-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The SBAR Patient Engagement Pathway Tool /slideshow/the-sbar-patient-engagement-pathway-tool/266273436 sbarpatientengagementtoolqiposterkirstybramleydove-240212101807-e927f4c6
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ ]]>
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ ]]> Mon, 12 Feb 2024 10:18:06 GMT /slideshow/the-sbar-patient-engagement-pathway-tool/266273436 WessexAHSN@slideshare.net(WessexAHSN) The SBAR Patient Engagement Pathway Tool WessexAHSN The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sbarpatientengagementtoolqiposterkirstybramleydove-240212101807-e927f4c6-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The SBAR Patient Engagement Pathway Tool from Health Innovation Wessex
]]> 42 0 https://cdn.slidesharecdn.com/ss_thumbnails/sbarpatientengagementtoolqiposterkirstybramleydove-240212101807-e927f4c6-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Reducing medication related falls risk in patients with severe frailty /slideshow/reducing-medication-related-falls-risk-in-patients-with-severe-frailty/266273402 reducingmedicationrelatedfallsriskinpatientswithseverefrailtyjulietbellqiposter-240212101600-f10c906e
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Mon, 12 Feb 2024 10:16:00 GMT /slideshow/reducing-medication-related-falls-risk-in-patients-with-severe-frailty/266273402 WessexAHSN@slideshare.net(WessexAHSN) Reducing medication related falls risk in patients with severe frailty WessexAHSN The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/reducingmedicationrelatedfallsriskinpatientswithseverefrailtyjulietbellqiposter-240212101600-f10c906e-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Reducing medication related falls risk in patients with severe frailty from Health Innovation Wessex
]]> 56 0 https://cdn.slidesharecdn.com/ss_thumbnails/reducingmedicationrelatedfallsriskinpatientswithseverefrailtyjulietbellqiposter-240212101600-f10c906e-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Assessing the outcomes of structured medication reviews /slideshow/assessing-the-outcomes-of-structured-medication-reviews/266273374 garethmasonstructuredmedicationreviewevaluationproject-240212101357-290f2d2f
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ ]]>
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ ]]> Mon, 12 Feb 2024 10:13:57 GMT /slideshow/assessing-the-outcomes-of-structured-medication-reviews/266273374 WessexAHSN@slideshare.net(WessexAHSN) Assessing the outcomes of structured medication reviews WessexAHSN The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/garethmasonstructuredmedicationreviewevaluationproject-240212101357-290f2d2f-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Assessing the outcomes of structured medication reviews from Health Innovation Wessex
]]> 45 0 https://cdn.slidesharecdn.com/ss_thumbnails/garethmasonstructuredmedicationreviewevaluationproject-240212101357-290f2d2f-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Polypharmacy SMR reviews in outpatient bone health clinics /slideshow/polypharmacy-smr-reviews-in-outpatient-bone-health-clinics/266273304 polypharmacysmrreviewsinoutpatientbonehealthclinicsdulaaliehaji-beic-240212100908-e598f261
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Mon, 12 Feb 2024 10:09:07 GMT /slideshow/polypharmacy-smr-reviews-in-outpatient-bone-health-clinics/266273304 WessexAHSN@slideshare.net(WessexAHSN) Polypharmacy SMR reviews in outpatient bone health clinics WessexAHSN The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/polypharmacysmrreviewsinoutpatientbonehealthclinicsdulaaliehaji-beic-240212100908-e598f261-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Polypharmacy SMR reviews in outpatient bone health clinics from Health Innovation Wessex
]]> 31 0 https://cdn.slidesharecdn.com/ss_thumbnails/polypharmacysmrreviewsinoutpatientbonehealthclinicsdulaaliehaji-beic-240212100908-e598f261-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines /slideshow/polypharmacy-reviews-of-asthma-and-copd-patients-over-65-and-10-or-more-medicines/266273286 chiomannamdipolypharmacyreviewsofasthmaandcopdpatientsover65and10ormoremedicinesposter-240212100648-8c32c3cf
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Mon, 12 Feb 2024 10:06:48 GMT /slideshow/polypharmacy-reviews-of-asthma-and-copd-patients-over-65-and-10-or-more-medicines/266273286 WessexAHSN@slideshare.net(WessexAHSN) Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines WessexAHSN The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/chiomannamdipolypharmacyreviewsofasthmaandcopdpatientsover65and10ormoremedicinesposter-240212100648-8c32c3cf-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines from Health Innovation Wessex
]]> 34 0 https://cdn.slidesharecdn.com/ss_thumbnails/chiomannamdipolypharmacyreviewsofasthmaandcopdpatientsover65and10ormoremedicinesposter-240212100648-8c32c3cf-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement /slideshow/evaluating-the-impact-of-a-specialist-frailty-multidisciplinary-team-pathway-with-clinical-pharmacist-involvement/266272841 alexspurlingevaluatingtheimpactofaspecialistfrailtymultidisciplinaryteampathwaywithclinicalpharmacis-240212093037-5d65d77b
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Mon, 12 Feb 2024 09:30:37 GMT /slideshow/evaluating-the-impact-of-a-specialist-frailty-multidisciplinary-team-pathway-with-clinical-pharmacist-involvement/266272841 WessexAHSN@slideshare.net(WessexAHSN) Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement WessexAHSN The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/alexspurlingevaluatingtheimpactofaspecialistfrailtymultidisciplinaryteampathwaywithclinicalpharmacis-240212093037-5d65d77b-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement from Health Innovation Wessex
]]> 20 0 https://cdn.slidesharecdn.com/ss_thumbnails/alexspurlingevaluatingtheimpactofaspecialistfrailtymultidisciplinaryteampathwaywithclinicalpharmacis-240212093037-5d65d77b-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Genomics strategy and implementation in the NHS in England /slideshow/genomics-strategy-and-implementation-in-the-nhs-in-england/265099645 suehillcsconferenceslidesnov23v0-240103133454-7f5dfb46
Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer. ]]>
Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer. ]]> Wed, 03 Jan 2024 13:34:54 GMT /slideshow/genomics-strategy-and-implementation-in-the-nhs-in-england/265099645 WessexAHSN@slideshare.net(WessexAHSN) Genomics strategy and implementation in the NHS in England WessexAHSN Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/suehillcsconferenceslidesnov23v0-240103133454-7f5dfb46-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer.
Genomics strategy and implementation in the NHS in England from Health Innovation Wessex
]]> 502 0 https://cdn.slidesharecdn.com/ss_thumbnails/suehillcsconferenceslidesnov23v0-240103133454-7f5dfb46-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pharmacogenomics into practice - stroke services and a systems approach /slideshow/pharmacogenomics-into-practice-stroke-services-and-a-systems-approach/265099568 richardmarigold-240103133052-97a98672
Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust]]>
Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust]]> Wed, 03 Jan 2024 13:30:52 GMT /slideshow/pharmacogenomics-into-practice-stroke-services-and-a-systems-approach/265099568 WessexAHSN@slideshare.net(WessexAHSN) Pharmacogenomics into practice - stroke services and a systems approach WessexAHSN Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/richardmarigold-240103133052-97a98672-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust
Pharmacogenomics into practice - stroke services and a systems approach from Health Innovation Wessex
]]> 289 0 https://cdn.slidesharecdn.com/ss_thumbnails/richardmarigold-240103133052-97a98672-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pharmacogenomics in Practice - Dr Hayley Wickens /WessexAHSN/pharmacogenomics-in-practice-dr-hayley-wickens hayleywickenspharmacogenomicsinpractice-240103132211-f6d8c75f
Pharmacogenomics in Practice by Dr Hayley Wickens, Consultant Pharmacist Genomic Medicine, Central and South Genomic Medicine Service Alliance]]>
Pharmacogenomics in Practice by Dr Hayley Wickens, Consultant Pharmacist Genomic Medicine, Central and South Genomic Medicine Service Alliance]]> Wed, 03 Jan 2024 13:22:11 GMT /WessexAHSN/pharmacogenomics-in-practice-dr-hayley-wickens WessexAHSN@slideshare.net(WessexAHSN) Pharmacogenomics in Practice - Dr Hayley Wickens WessexAHSN Pharmacogenomics in Practice by Dr Hayley Wickens, Consultant Pharmacist Genomic Medicine, Central and South Genomic Medicine Service Alliance <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hayleywickenspharmacogenomicsinpractice-240103132211-f6d8c75f-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Pharmacogenomics in Practice by Dr Hayley Wickens, Consultant Pharmacist Genomic Medicine, Central and South Genomic Medicine Service Alliance
Pharmacogenomics in Practice - Dr Hayley Wickens from Health Innovation Wessex
]]> 372 0 https://cdn.slidesharecdn.com/ss_thumbnails/hayleywickenspharmacogenomicsinpractice-240103132211-f6d8c75f-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Working with patients to support transformational healthcare /slideshow/working-with-patients-transformational-healthcare/265099300 dianaeccles-workingwithpatients-transformationalhealthcare-240103131742-0b923881
Working with patients to support transformational healthcare by Professor Diana Eccles, Dean of Medicine, University of Southampton]]>
Working with patients to support transformational healthcare by Professor Diana Eccles, Dean of Medicine, University of Southampton]]> Wed, 03 Jan 2024 13:17:42 GMT /slideshow/working-with-patients-transformational-healthcare/265099300 WessexAHSN@slideshare.net(WessexAHSN) Working with patients to support transformational healthcare WessexAHSN Working with patients to support transformational healthcare by Professor Diana Eccles, Dean of Medicine, University of Southampton <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/dianaeccles-workingwithpatients-transformationalhealthcare-240103131742-0b923881-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Working with patients to support transformational healthcare by Professor Diana Eccles, Dean of Medicine, University of Southampton
Working with patients to support transformational healthcare from Health Innovation Wessex
]]> 267 0 https://cdn.slidesharecdn.com/ss_thumbnails/dianaeccles-workingwithpatients-transformationalhealthcare-240103131742-0b923881-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Generation study by Alice Tuff-Lacey /slideshow/the-generation-study-by-alice-tufflacey/265097490 alicetuff-lacey-240103114631-1c2a49db
The Generation study: exploring the use of WGS in newborns by Alice Tuff-Lacey, Programme Lead, Newborn Genomes Programme, Genomics England]]>
The Generation study: exploring the use of WGS in newborns by Alice Tuff-Lacey, Programme Lead, Newborn Genomes Programme, Genomics England]]> Wed, 03 Jan 2024 11:46:31 GMT /slideshow/the-generation-study-by-alice-tufflacey/265097490 WessexAHSN@slideshare.net(WessexAHSN) The Generation study by Alice Tuff-Lacey WessexAHSN The Generation study: exploring the use of WGS in newborns by Alice Tuff-Lacey, Programme Lead, Newborn Genomes Programme, Genomics England <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/alicetuff-lacey-240103114631-1c2a49db-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Generation study: exploring the use of WGS in newborns by Alice Tuff-Lacey, Programme Lead, Newborn Genomes Programme, Genomics England
The Generation study by Alice Tuff-Lacey from Health Innovation Wessex
]]> 343 0 https://cdn.slidesharecdn.com/ss_thumbnails/alicetuff-lacey-240103114631-1c2a49db-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients.pdf /slideshow/to-evaluate-the-benefits-of-structured-medication-reviews-in-elderly-chinese-patientspdf/263726770 toevaluatethebenefitsofstructuredmedicationreviewsinelderlychinesepatients-231121164414-57dba1f9
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Tue, 21 Nov 2023 16:44:14 GMT /slideshow/to-evaluate-the-benefits-of-structured-medication-reviews-in-elderly-chinese-patientspdf/263726770 WessexAHSN@slideshare.net(WessexAHSN) To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients.pdf WessexAHSN The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/toevaluatethebenefitsofstructuredmedicationreviewsinelderlychinesepatients-231121164414-57dba1f9-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients.pdf from Health Innovation Wessex
]]> 19 0 https://cdn.slidesharecdn.com/ss_thumbnails/toevaluatethebenefitsofstructuredmedicationreviewsinelderlychinesepatients-231121164414-57dba1f9-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Review of patients on high dose opioids at Living Well PCN.pdf /slideshow/review-of-patients-on-high-dose-opioids-at-living-well-pcnpdf/263726660 reviewofpatientsonhighdoseopioidsatlivingwellpcn-231121164046-7a672494
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Review of patients on high dose opioids at Living Well PCN, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ ]]>
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Review of patients on high dose opioids at Living Well PCN, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ ]]> Tue, 21 Nov 2023 16:40:46 GMT /slideshow/review-of-patients-on-high-dose-opioids-at-living-well-pcnpdf/263726660 WessexAHSN@slideshare.net(WessexAHSN) Review of patients on high dose opioids at Living Well PCN.pdf WessexAHSN The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Review of patients on high dose opioids at Living Well PCN, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/reviewofpatientsonhighdoseopioidsatlivingwellpcn-231121164046-7a672494-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Review of patients on high dose opioids at Living Well PCN, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Review of patients on high dose opioids at Living Well PCN.pdf from Health Innovation Wessex
]]> 52 0 https://cdn.slidesharecdn.com/ss_thumbnails/reviewofpatientsonhighdoseopioidsatlivingwellpcn-231121164046-7a672494-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Re-establishing autonomy in elderly frail patients.pdf /slideshow/reestablishing-autonomy-in-elderly-frail-patientspdf/263726553 re-establishingautonomyinelderlyfrailpatients-231121163654-63b97438
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Tue, 21 Nov 2023 16:36:53 GMT /slideshow/reestablishing-autonomy-in-elderly-frail-patientspdf/263726553 WessexAHSN@slideshare.net(WessexAHSN) Re-establishing autonomy in elderly frail patients.pdf WessexAHSN The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/re-establishingautonomyinelderlyfrailpatients-231121163654-63b97438-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Re-establishing autonomy in elderly frail patients.pdf from Health Innovation Wessex
]]> 51 0 https://cdn.slidesharecdn.com/ss_thumbnails/re-establishingautonomyinelderlyfrailpatients-231121163654-63b97438-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Improving Medication Reviews using the NO TEARS Tool.pdf /slideshow/improving-medication-reviews-using-the-no-tears-toolpdf/263726445 improvingmedicationreviewsusingthenotearstool-231121163301-d1a8e672
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]>
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/]]> Tue, 21 Nov 2023 16:33:01 GMT /slideshow/improving-medication-reviews-using-the-no-tears-toolpdf/263726445 WessexAHSN@slideshare.net(WessexAHSN) Improving Medication Reviews using the NO TEARS Tool.pdf WessexAHSN The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/improvingmedicationreviewsusingthenotearstool-231121163301-d1a8e672-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications. Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely. To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here. For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Improving Medication Reviews using the NO TEARS Tool.pdf from Health Innovation Wessex
]]> 166 0 https://cdn.slidesharecdn.com/ss_thumbnails/improvingmedicationreviewsusingthenotearstool-231121163301-d1a8e672-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-WessexAHSN-48x48.jpg?cb=1734114715 We improve people’s health, achieve excellence in healthcare and boost innovation and growth in our region’s life sciences and healthcare sector. We connect academics, NHS, industry and others to bring fresh energy to old problems, inspired thinking to new ones and to spread innovation and best practice. We use our unique position to act as a catalyst across the whole healthcare system. We foster collaboration across our network of partners and drive improvement, including excellent outcomes for patients as well as economic growth. healthinnovationwessex.org.uk https://cdn.slidesharecdn.com/ss_thumbnails/iepfinalreporthealthinnovationnetworknovember2024-241204173619-0224cd7b-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/innovation-ecosystem-programme-rapid-insight-recommendations-november-2024-pdf/273838536 Innovation Ecosystem P... https://cdn.slidesharecdn.com/ss_thumbnails/slidesforsharing2-241202155010-1c5563ed-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/data-digital-and-ai-strategic-event-slides/273781325 Data, Digital and AI s... https://cdn.slidesharecdn.com/ss_thumbnails/slidesforsharing-241202105916-8cdb3d62-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/strategic-event-slides-data-digital-and-ai/273774963 Strategic Event slides...